Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: 888 CEO Sells GBP780,000 In Shares

Wed, 18th Nov 2020 15:11

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

----------

888 Holdings PLC - Gibraltar-based online gambling platform operator - Chief Executive Officer Itai Pazner sells 300,000 shares at 260p, worth GBP780,000, on Monday. Still has 819,796 shares, a 0.2% stake.

----------

Imperial Brands PLC - Bristol-based smoking and vaping products - Non-Executive Director Robert Kunze-Concewitz buys 15,000 shares at GBP15.17, worth GBP227,623, on Wednesday.

----------

Oxford Instruments PLC - Finance Director Gavin Hill sells 5,500 shares at average GBP19.65, worth GBP108,091, on Monday.

----------

easyJet PLC - Luton Airport-based budget carrier - Non-Executive Director David Robbie buys 10,000 shares at GBP7.56, worth GBP75,603. General Counsel Maaike de Bie and associates buy 15,498 shares at GBP7.71 to GBP7.78, worth about GBP120,000. All on Tuesday.

----------

Domino's Pizza Group PLC - Milton Keynes, Buckinghamshire-based pizza delivery master franchiser - Non-Executive Director Natalia Barsegiyan buys 20,000 shares at GBP3.29, worth GBP65,800, on Tuesday.

----------

Tiziana Life Sciences PLC - London-based biotech company focused on oncology, inflammation and infectious diseases - Executive Chair Gabriele Cerrone buys 45,000 shares via Panetta Partners Ltd at 84p, worth GBP37,800, on Wednesday. Now has a 34.1% stake.

----------

Picton Property Income Ltd - real estate investment trust for commercial property - Helen Jones, associate of Non-Executive Director Richard Jones, buys 26,929 shares at 73.34p on Thursday last week. She also buys 26,916 shares at 73.37p and 73.38p on Monday. The 53,845 shares, together worth about GBP39,500, are her only holding. Richard Jones, a former Aviva PLC executive, joined the Picton board on September 1.

----------

Luceco PLC - Telford, Shropshire-based LED lighting products manufacturer - As reported on Tuesday, Chair Giles Brand on Monday sold 4.0 million shares, a 2.5% stake, via EPE Special Opportunities Ltd investee Epic Investments LLP at 250p, worth GBP10 million. ESO now holds 40.1 million shares in Luceco, a 24.9% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Nov 2020 20:17

UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus

UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus

Read more
2 Nov 2020 18:14

IN BRIEF: Tiziana To Start Brazil Clinical Trial For Covid-19 Patients

IN BRIEF: Tiziana To Start Brazil Clinical Trial For Covid-19 Patients

Read more
29 Oct 2020 16:04

Court gives Tiziana capital reduction the nod

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Thursday that the capital reduction required for the demerger of StemPrintER Sciences, and to enable the ultimate allotment of Accustem Sciences shares to its shareholders, has been sanctioned by the court.

Read more
30 Sep 2020 12:18

UK EARNINGS SUMMARY: City Pub In Signs Of Recovery After Tough Interim

UK EARNINGS SUMMARY: City Pub In Signs Of Recovery After Tough Interim

Read more
25 Sep 2020 16:05

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
17 Sep 2020 15:51

IN BRIEF: Tiziana To Kick Off Clinical Study On Foralumab

IN BRIEF: Tiziana To Kick Off Clinical Study On Foralumab

Read more
16 Sep 2020 11:55

Tiziana Plans 2020 London IPO Of StemPrintER, SPARE Assets

Tiziana Plans 2020 London IPO Of StemPrintER, SPARE Assets

Read more
24 Aug 2020 14:33

IN BRIEF: Tiziana Life Sciences Gets US Patent On TZLS-501 In Covid-19

IN BRIEF: Tiziana Life Sciences Gets US Patent On TZLS-501 In Covid-19

Read more
24 Aug 2020 14:19

Tiziana gets US patent for 'TZLS-501' antibody

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Monday that the United States Patent and Trademark Office (USPTO) has granted a patent for methods and use of fully human monoclonal antibody 'TZLS-501' that recognised both IL-6 receptor (IL-6R) and IL-6 receptor complex with IL-6 (IL-6R/IL-6) for prophylactic and therapeutic intervention for human diseases.

Read more
21 Aug 2020 09:34

Tiziana Life Sciences Gets US Patent For Milciclib In Cancer

Tiziana Life Sciences Gets US Patent For Milciclib In Cancer

Read more
18 Aug 2020 18:36

IN BRIEF: Tiziana Gets US Patent For Foralumab As Crohn's Treatment

IN BRIEF: Tiziana Gets US Patent For Foralumab As Crohn's Treatment

Read more
5 Aug 2020 22:03

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

Read more
4 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Read more
4 Aug 2020 11:07

Tiziana inks four deals for development of Covid-19 treatment

(Sharecast News) - Biotechnology company Tiziana Life Sciences has signed agreements with four contract research organisations, it announced on Tuesday, to expedite the clinical development of 'TZLS-501' - a novel, fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for the treatment of Covid-19 patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.